Gender Inequity in Academic Publishing ‘Marginalizes an Entire Crucial Talent Pool’
This Blog post represents a partnership between the Women in Medicine Summit and Healio Women in Oncology. An excerpt appears blow, and please find the full length piece at Healio’s Women in Oncology Blog
Gender equity has been identified as a problem in academic medicine for decades — including publishing — and it marginalizes an entire crucial talent pool.
Improving gender equity advances innovation, collaboration and progress. While the COVID-19 pandemic elevated the research efforts of men in academic medicine, women’s research efforts regressed due to increased competing pressures in career or clinical roles. Improved transparency and implementation of policies can improve gender parity and are a must for all areas of academia, including publishing.
Women in Lymphoma
The mission of Women in Lymphoma (WiL) is to advocate for and promote equal gender representation in all aspects of academic medicine, globally.
One of WiL’s main missions is to increase women’s visibility at conferences, on panels, in lymphoma leadership committees and in research.
There are numerous opportunities for women to participate on the global scale. Disappointingly, there remain many panels, large clinical trials and steering committees where women make up a small proportion of key leaders. WiL has demonstrated that there is immense talent globally, and these disparities must be noted and addressed. WiL emphasizes celebrating the successes of our members, and we make it a point to highlight WiL contributions at all major meetings.
About the authors: Carla Casulo, MD, is a medical oncologist at Wilmot Cancer Institute and associate professor at University of Rochester. Eliza Hawkes, MD, is a medical oncologist at Austin Health, Australia, and associate professor at the School of Public Health and Preventative Medicine at Monash University.
